IRVINE, Calif.–(BUSINESS WIRE)–Endologix, Inc. (Nasdaq:ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced that it will present at the following two investor conferences in November: Conference: Stephens NY Investment Conference Location: New York, NY Date: Tuesday, November 6, 2018 Presentation: 7:30 a.m. ET Speakers: Vaseem Mahboob, […]
Financial
REVA to Hold Third Quarter 2018 Financial Results Call
SAN DIEGO, Oct. 29, 2018 (GLOBE NEWSWIRE) — REVA Medical, Inc. (ASX: RVA) (“REVA” or the “Company”) has scheduled a conference call to review its third quarter 2018 financial results and provide a business update. The call is scheduled for 2:00 p.m. US PST on Monday, November 5, 2018 (which […]
Hemostemix Announces OTCQB Listing and DTC Eligibility
CALGARY, Alberta, Oct. 30, 2018 (GLOBE NEWSWIRE) — Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX VENTURE: HEM; OTCQB: HMTXF) is pleased to announce the Company has been approved for up-listing its common shares for trading on the OTCQB Venture Market, a US trading platform that is operated by the OTC […]
InspireMD to Report Third Quarter 2018 Financial Results and Provide Business Update on Tuesday, November 6
TEL AVIV, Israel, Oct. 30, 2018 (GLOBE NEWSWIRE) — InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of carotid artery disease, announced today that it will host a conference call and webcast on Tuesday, November 6, […]
Merit Medical Reports Earnings for Third Quarter of 2018
SOUTH JORDAN, Utah, Oct. 25, 2018 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, today announced revenue of $221.7 million for the quarter ended […]
Cerenis Therapeutics Announces Its Cash Position for Q3 2018 And Highlights the Progress Made over the Period and Key Perspectives for the end of 2018
October 25, 2018 12:00 PM Eastern Daylight Time TOULOUSE, France & LAKELAND, Fla.–(BUSINESS WIRE)–Regulatory News: Cerenis Therapeutics (Paris:CEREN) (FR0012616852 – CEREN – PEA PME eligible), an international biopharmaceutical company dedicated to the discovery and development of HDL-based innovative therapies for treating cardiovascular, metabolic diseases, and HDL platform technologies today announced its cash […]
Amarin To Report Third Quarter 2018 Results and Host Conference Call On November 1, 2018
BEDMINSTER, N.J. and DUBLIN, Ireland, Oct. 25, 2018 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN), a pharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, today announced that it will host a conference call with members of Amarin senior management to discuss the company’s third quarter 2018 […]
LivaNova to Present at the Stifel 2018 Healthcare Conference
LONDON–(BUSINESS WIRE)–LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology company, today announced that Damien McDonald, Chief Executive Officer, will present at the Stifel 2018 Healthcare Conference on Tuesday, Nov. 13 in New York at 9:30 a.m. Eastern Standard Time. The discussion will be available to all interested parties through a live […]
Lexington Provides Q3 Corporate Review
VANCOUVER, British Columbia, Oct. 23, 2018 (GLOBE NEWSWIRE) — Lexington Biosciences, Inc. (CSE: LNB) (OTCQB: LXGTF) (the “Company” or “Lexington”), a development-stage medical device company, is pleased to review activities undertaken during Q3 of 2018. Over the summer, the Company completed its first phase of clinical testing at Diablo Clinical […]
Edwards Lifesciences Reports Third Quarter Results
IRVINE, Calif., Oct. 23, 2018 /PRNewswire/ — Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today reported financial results for the quarter ended September 30, 2018. Third Quarter and Recent Highlights: Sales grew 10 percent; underlying1 sales grew 11 percent Global THVT sales grew 16 […]
Recent
Popular
- No commented posts yet